The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a partly hydrogenated isoindolinyl ring, processes for their preparation and antibacterial agents and feed additives containing these compounds.
Quinolone- and naphthyridonecarboxylic acid derivatives
申请人:Bayer Aktiengesellschaft
公开号:US05457104A1
公开(公告)日:1995-10-10
The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which have hydrogen in the 6-position, to processes for their preparation, and to antibacterial compositions and feed additives containing them.
The invention relates to the field of blood clotting, to novel compounds of formula (I),
to a method for their production and to the use of these compounds as active ingredients in medicaments for preventing and/or treating diseases. The compounds are factor Xa inhibitors.
7-Isoindolinyl-chinolon- und naphthyridoncarbonsäure-Derivate
申请人:BAYER AG
公开号:EP0520240A1
公开(公告)日:1992-12-30
Die Erfindung betrifft neue Chinolon- und Naphthyridoncarbonsäure-Derivate, die in 7-Stellung durch einen partiell hydrierten Isoindolinylring substituiert sind, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel und Futterzusatzstoffe.
Die Erfindung betrifft neue 8-Vinyl- und 8-Ethinyl-chinoloncarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel und Futterzusatzstoffe.